Phaseline

Companies › Boston Medical Group

Boston Medical Group: clinical trials, targets and expected readouts

1 active drug program in 1 registered trial: 1 Phase 3; Psychiatry.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
TENS therapy (transcutaneous posterior tibial nerve stimulation)
Transcutaneous electrostimulation of the posterior tibial nerve
–Phase 3Premature Ejaculation–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT06425224TENS therapy (transcutaneous posterior tibial nerve stimulation)Phase 3Premature EjaculationPsychiatryJun 2025

Targets

No annotated target.

Companies with the same targets

–

Companies built like this

Curemark Emalex Biosciences Transcend Therapeutics Gedeon Richter Cybin IRL

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.